Sarah Cannon, the Cancer Institute of Hospital Corporation of America (HCA), merged with Genospace, LLC, a cloud-based software company focused on advancing personalized medicine, to become a wholly-owned subsidiary. By joining forces, Sarah Cannon and Genospace will harness and use molecular profiling data to more effectively match cancer patients to cutting-edge therapies in clinical trials.
Waller represented HCA as lead counsel in the transaction.
For more information, see media coverage here.
Whether a current or prospective client, we are here to help your business thrive. Please send us a message and we will respond to your needs as soon as possible.Send us a message